Chromatin clearance in C57Bl/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells.
Chromatin is an important autoantigen in the pathogenesis of systemic lupus erythematosus (SLE) as an immunogen and as a part of nephritogenic immune complexes. Earlier studies focused on clearance of DNA. However, DNA released into the circulation from dying cells is found associated with histones in nucleosomes. The liver is the major organ involved in clearance of chromatin from the circulation of mice. Heparan sulphate proteoglycans (HSPG) have been implicated in the clearance of various charged molecules. Receptor-mediated clearance of ssDNA by the liver has also been reported. Because chromatin contains positively charged histones in addition to DNA, we wished to determine if HSPG and/or DNA receptors are involved in chromatin clearance. The rate of clearance of H1-stripped chromatin from the bloodstream of C57Bl/10 mice was markedly decreased by prior treatment of mice with Heparinase I. Clearance was also inhibited by heparin, heparan sulphate, and DNA, but not by colominic acid. DNA was the most effective inhibitor of clearance and released chromatin from sites of clearance. Depletion of Kupffer cells and splenic macrophages using liposome-encapsulated Clodronate (dichloromethylene bisphosphonate) markedly inhibited chromatin clearance. These data suggest that chromatin clearance is mediated by charge interactions with cell surface HSPG and by DNA receptors. Clearance and degradation of chromatin require functional macrophages in the liver and spleen.
Du Clos
T W
TW
Department of Veterans Affairs Medical Center, Albuquerque, NM 87108, USA. tduclos@unm.edu
Volzer
M A
MA
Hahn
F F
FF
Xiao
R
R
Mold
C
C
Searles
R P
RP
D000818:Animals; D002843:Chromatin / Q000378:metabolism*; D004002:Clodronic Acid / Q000008:administration & dosage; D004277:DNA, Single-Stranded / Q000008:administration & dosage; D005260:Female; D019812:Heparan Sulfate Proteoglycans / Q000097:blood / Q000378:metabolism*; D006493:Heparin / Q000008:administration & dosage; D019763:Heparin Lyase / Q000494:pharmacology; D006497:Heparan Sulfate / Q000494:pharmacology; D006657:Histones / Q000097:blood; D007165:Immunosuppression Therapy; D007457:Iodine Radioisotopes / Q000378:metabolism; D007728:Kupffer Cells / Q000187:drug effects / Q000378:metabolism*; D008099:Liver / Q000166:cytology / Q000378:metabolism; D008264:Macrophages; D051379:Mice; D008810:Mice, Inbred C57BL; D012313:RNA / Q000008:administration & dosage; D011956:Receptors, Cell Surface / Q000097:blood / Q000378:metabolism*
D002843:Chromatin; D004002:Clodronic Acid; D004277:DNA, Single-Stranded; D019812:Heparan Sulfate Proteoglycans; D006493:Heparin; D019763:Heparin Lyase; D006497:Heparan Sulfate; D006657:Histones; D007457:Iodine Radioisotopes; D012313:RNA; D011956:Receptors, Cell Surface; C086020:glycosaminoglycan receptor